Biomedical Engineering Reference
In-Depth Information
30. Roghani M, Mansukhani A, Dell'Era P et al. Heparin increases the affinity of basic fibroblast
growth factor for its receptor but is not required for binding. J Biol Chem 1994; 269:3976-84.
31. Lyon M, Rushton G, Gallagher JT. The interaction of the transforming growth factor-betas with
heparin/heparan sulfate is isoform-specific. J Biol Chem 1997; 272:18000-6.
32. Ruppert R, Hoffmann E, Sebald W. Human bone morphogenetic protein 2 contains a
heparin-binding site which modifies its biological activity. Eur J Biochem 1996; 237:295-302.
33. Schroeder-Tefft JA, Bentz H, Estridge TD. Collagen and heparin matrices for growth factor deliv-
ery. J Control Release 1997; 49:291-298
34. Sakiyama-Elbert SE, Hubbell JA. Development of fibrin derivatives for controlled release of hep-
arin- binding growth factors. J Control Release 2000; 65:389-402.
35. Winn SR, Uludag H, Hollinger JO. Carrier systems for bone morphogenetic proteins. Clin Orthop
1999; S95-106.
36. Uludag H, D'Augusta D, Palmer R et al. Characterization of rhBMP-2 pharmacokinetics implanted
with biomaterial carriers in the rat ectopic model. J Biomed Mater Res 1999; 46:193-202.
37. Uludag H, Friess W, Williams D et al. rhBMP-collagen sponges as osteoinductive devices: Effects
of in vitro sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics. Ann NY
Acad Sci 1999; 875:369-78.
38. Ziegler J, Mayr-Wohlfart U, Kessler S et al. Adsorption and release properties of growth factors
from biodegradable implants. J Biomed Mater Res 2002; 59:422-8.
39. Urist MR. Experimental delivery systems for bone morphogenetic protein, Vol. 2. Wise DL, Altobelli
DE, Schwartz ER et al, eds. Boston: Dekker M, 1994:1093-1133.
40. Lindholm TS, Gao TJ. Functional carriers for bone morphogenetic proteins. Ann Chir Gynaecol
Suppl 1993; 207:3-12
41. Metsger DS, Driskell TD, Paulsrud JR. Tricalcium phosphate ceramic—a resorbable bone implant:
Review and current status. J Am Dent Assoc 1982; 105:1035-8.
42. Holmes RE, Bucholz RW, Mooney V. Porous hydroxyapatite as a bone-graft substitute in meta-
physeal defects. A histometric study. J Bone Joint Surg Am 1986; 68:904-11.
43. Damien CJ, Parsons JR. Bone graft and bone graft substitutes: A review of current technology and
applications. J Appl Biomater 1991; 2:187-208.
44. Ripamonti U, Ma SS, van den Heever B et al. Osteogenin, a bone morphogenetic protein, adsorbed
on porous hydroxyapatite substrata, induces rapid bone differentiation in calvarial defects of adult
primates. Plast Reconstr Surg 1992; 90:382-93.
45. Ono I, Ohura T, Murata M et al. A study on bone induction in hydroxyapatite combined with
bone morphogenetic protein. Plast Reconstr Surg 1992; 90:870-9.
46. Ono I, Gunji H, Suda K et al. Bone induction of hydroxyapatite combined with bone morphoge-
netic protein and covered with periosteum. Plast Reconstr Surg 1995; 95:1265-72.
47. Urist MR, Lietze A, Dawson E. Beta-tricalcium phosphate delivery system for bone morphogenetic
protein. Clin Orthop 1984; 277-80.
48. Laffargue P, Hildebrand HF, Rtaimate M et al. Evaluation of human recombinant bone morpho-
genetic protein-2-loaded tricalcium phosphate implants in rabbits' bone defects. Bone 1999;
25:55S-58S.
49. Kuboki Y, Saito T, Murata M et al. Two distinctive BMP-carriers induce zonal chondrogenesis
and membranous ossification, respectively; geometrical factors of matrices for cell-differentiation.
Connect Tissue Res 1995; 32:219-226
50. Tsuruga E, Takita H, Itoh H et al. Pore size of porous hydroxyapatite as the cell-substratum
controls BMP-induced osteogenesis. J Biochem (Tokyo) 1997; 121:317-24.
51. Kuboki Y, Jin Q, Takita H. Geometry of carriers controlling phenotypic expression in BMP-induced
osteogenesis and chondrogenesis. J Bone Joint Surg Am 2001; 83-A:S105-15.
52. Urist MR, Nilsson O, Rasmussen J et al. Bone regeneration under the influence of a bone mor-
phogenetic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in
dogs. Clin Orthop 1987; 295-304.
53. Klein CP, Driessen AA, de Groot K et al. Biodegradation behavior of various calcium phosphate
materials in bone tissue. J Biomed Mater Res 1983; 17:769-784.
54. Klein CP, Driessen AA, de Groot K. Relationship between the degradation behaviour of calcium
phosphate ceramics and their physical-chemical characteristics and ultrastructural geometry.
Biomaterials 1984; 5:157-160.
55. Hollinger JO, Battistone GC. Biodegradable bone repair materials. Synthetic polymers and ceram-
ics. Clin Orthop 1986; 290-305.
56. Benhayoune H, Jallot E, Laquerriere P et al. Integration of dense HA rods into cortical bone.
Biomaterials 2000; 21:235-42.
57. Lu J, Descamps M, Dejou J et al. The biodegradation mechanism of calcium phosphate biomaterials
in bone. J Biomed Mater Res 2002; 63:408-12.
Search WWH ::
Custom Search